Literature DB >> 19907332

Human papillomavirus infections among couples in new sexual relationships.

Ann N Burchell1, Pierre-Paul Tellier, James Hanley, François Coutlée, Eduardo L Franco.   

Abstract

BACKGROUND: No studies have examined human papillomavirus (HPV) infections among couples early in their sexual relationships when transmission is most likely. Our objective was to describe the distribution of HPV infections among recently formed couples, using the partnership as the unit of analysis.
METHODS: Women aged 18-24 years attending a university or junior college in Montreal enrolled in a longitudinal study with their new male partners. Self-collected vaginal swabs and clinician-collected swabs from the penis and scrotum were tested for 36 HPV genotypes. Participants self-reported sexual behavior in computerized questionnaires. We analyzed patterns of genital HPV infection in 263 couples using data obtained at enrollment.
RESULTS: Couples had engaged in vaginal sex for a median of 3.9 months. HPV was detected in 64% (169/263) of couples. In 41% (109/263), both partners harbored the same HPV type-nearly 4 times more than expected if HPV status of partners were uncorrelated. There were 583 type-specific HPV infections among 169 couples for whom at least one partner was infected. Of these, 42% were of the same type for both partners (95% confidence interval = 36%-47%). This rose from 25% among those engaging in vaginal sex for less than 2 months to 68% among those at 5 to 6 months.
CONCLUSIONS: Although HPV is common, detection of the same type in persons initiating a sex relationship would be rare given type-specific prevalence rates. The high degree of concordance we found suggests a high probability of transmission.

Entities:  

Mesh:

Year:  2010        PMID: 19907332      PMCID: PMC8313299          DOI: 10.1097/EDE.0b013e3181c1e70b

Source DB:  PubMed          Journal:  Epidemiology        ISSN: 1044-3983            Impact factor:   4.822


  34 in total

1.  Chlorinated drinking-water; chlorination by-products; some other halogenated compounds; cobalt and cobalt compounds. International Agency for Research on Cancer (IARC) Working Group, Lyon, 12-19 June 1990.

Authors: 
Journal:  IARC Monogr Eval Carcinog Risks Hum       Date:  1991

2.  Natural history of genital warts.

Authors:  J D Oriel
Journal:  Br J Vener Dis       Date:  1971-02

3.  Low concordance of genital human papillomavirus (HPV) lesions and viral types in HPV-infected women and their male sexual partners.

Authors:  M I Hippeläinen; M Yliskoski; S Syrjänen; J Saastamoinen; M Hippeläinen; S Saarikoski; K Syrjänen
Journal:  Sex Transm Dis       Date:  1994 Mar-Apr       Impact factor: 2.830

4.  Genital human papillomavirus infection in men: incidence and risk factors in a cohort of university students.

Authors:  Jeffrey M Partridge; James P Hughes; Qinghua Feng; Rachel L Winer; Bethany A Weaver; Long-Fu Xi; Michael E Stern; Shu-Kuang Lee; Sandra F O'Reilly; Stephen E Hawes; Nancy B Kiviat; Laura A Koutsky
Journal:  J Infect Dis       Date:  2007-09-13       Impact factor: 5.226

5.  Influence of partner's infection status on prevalent human papillomavirus among persons with a new sex partner.

Authors:  Ann N Burchell; Pierre-Paul Tellier; James Hanley; François Coutlée; Eduardo L Franco
Journal:  Sex Transm Dis       Date:  2010-01       Impact factor: 2.830

6.  Genital human papillomavirus infection: incidence and risk factors in a cohort of female university students.

Authors:  Rachel L Winer; Shu-Kuang Lee; James P Hughes; Diane E Adam; Nancy B Kiviat; Laura A Koutsky
Journal:  Am J Epidemiol       Date:  2003-02-01       Impact factor: 4.897

7.  Genital human papillomavirus infection among male and female sex partners: prevalence and type-specific concordance.

Authors:  L A Baken; L A Koutsky; J Kuypers; M R Kosorok; S K Lee; N B Kiviat; K K Holmes
Journal:  J Infect Dis       Date:  1995-02       Impact factor: 5.226

8.  A cost-effectiveness analysis of adding a human papillomavirus vaccine to the Australian National Cervical Cancer Screening Program.

Authors:  Shalini Kulasingam; Luke Connelly; Elizabeth Conway; Jane S Hocking; Evan Myers; David G Regan; David Roder; Jayne Ross; Gerard Wain
Journal:  Sex Health       Date:  2007-09       Impact factor: 2.706

9.  Evaluating human papillomavirus vaccination programs.

Authors:  Al V Taira; Christopher P Neukermans; Gillian D Sanders
Journal:  Emerg Infect Dis       Date:  2004-11       Impact factor: 6.883

10.  Prevalence and determinants of human papillomavirus genital infection in men.

Authors:  S Franceschi; X Castellsagué; L Dal Maso; J S Smith; M Plummer; C Ngelangel; S Chichareon; J Eluf-Neto; K V Shah; P J F Snijders; C J L M Meijer; F X Bosch; N Muñoz
Journal:  Br J Cancer       Date:  2002-03-04       Impact factor: 7.640

View more
  39 in total

1.  Sexual transmission of oral human papillomavirus infection among men.

Authors:  Kristina R Dahlstrom; Ann N Burchell; Agnihotram V Ramanakumar; Allita Rodrigues; Pierre-Paul Tellier; James Hanley; François Coutlée; Eduardo L Franco
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2014-11-12       Impact factor: 4.254

2.  Determinants of prevalent human papillomavirus in recently formed heterosexual partnerships: a dyadic-level analysis.

Authors:  Ann N Burchell; Allita Rodrigues; Veronika Moravan; Pierre-Paul Tellier; James Hanley; François Coutlée; Eduardo L Franco
Journal:  J Infect Dis       Date:  2014-03-27       Impact factor: 5.226

3.  Genital human papillomavirus (HPV) concordance in heterosexual couples.

Authors:  Alan G Nyitray; Lynette Menezes; Beibei Lu; Hui-Yi Lin; Dan'elle Smith; Martha Abrahamsen; Mary Papenfuss; Christine Gage; Anna R Giuliano
Journal:  J Infect Dis       Date:  2012-04-26       Impact factor: 5.226

4.  Human Papillomavirus Viral Load and Transmission in Young, Recently Formed Heterosexual Couples.

Authors:  Michel D Wissing; Karolina Louvanto; Emilie Comète; Ann N Burchell; Mariam El-Zein; Allita Rodrigues; Pierre-Paul Tellier; François Coutlée; Eduardo L Franco
Journal:  J Infect Dis       Date:  2019-08-30       Impact factor: 5.226

5.  Hand-to-genital and genital-to-genital transmission of human papillomaviruses between male and female sexual partners (HITCH): a prospective cohort study.

Authors:  Talía Malagón; Karolina Louvanto; Michel Wissing; Ann N Burchell; Pierre-Paul Tellier; Mariam El-Zein; François Coutlée; Eduardo L Franco
Journal:  Lancet Infect Dis       Date:  2019-02-10       Impact factor: 25.071

6.  Update on Human Papillomavirus (HPV) Vaccines: An Advisory Committee Statement (ACS) National Advisory Committee on Immunization (NACI) .

Authors:  Dr M Dawar; Ms T Harris; Dr S McNeil
Journal:  Can Commun Dis Rep       Date:  2012-01-02

7.  Generic microtiter plate assay for triaging clinical specimens prior to genotyping of human papillomavirus DNA via consensus PCR.

Authors:  Véronique Legault; Ann Burchell; Patricia Goggin; Belinda Nicolau; Paul Brassard; Julie Guenoun; Pierre Forest; Marie-Hélène Mayrand; Eduardo Luis Franco; Francois Coutlée
Journal:  J Clin Microbiol       Date:  2011-09-21       Impact factor: 5.948

8.  Genital transmission of human papillomavirus in recently formed heterosexual couples.

Authors:  Ann N Burchell; François Coutlée; Pierre-Paul Tellier; James Hanley; Eduardo L Franco
Journal:  J Infect Dis       Date:  2011-10-07       Impact factor: 5.226

9.  Vaccination of Young Women Decreases Human Papillomavirus Transmission in Heterosexual Couples: Findings from the HITCH Cohort Study.

Authors:  Michel D Wissing; Ann N Burchell; Mariam El-Zein; Pierre-Paul Tellier; François Coutlée; Eduardo L Franco
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2019-09-05       Impact factor: 4.254

Review 10.  Human papillomavirus: what every provider should know.

Authors:  Britt K Erickson; Ronald D Alvarez; Warner K Huh
Journal:  Am J Obstet Gynecol       Date:  2012-09-14       Impact factor: 8.661

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.